Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ASCO Seeks More Aggressive Approach On Limiting Safety Data Collection

May 07 2012

• By Sue Sutter

Related Content

FDA Opts For Full, Rather Than Accelerated, Approval Of GSK’s <em>Votrient</em> In Sarcoma

Apr 27 2012

Targeted Safety Data Collection Needs International Agreement, Industry Tells FDA

May 07 2012

FDA’s Guide For Selectively Collecting Safety Data

May 07 2012

Merck, GSK Sarcoma Drugs Bring Different Efficacy Stories To FDA Panel Review

Mar 16 2012

Related Companies

GSK plc

Additional Topics

Clinical Trials Regulation Drug Approval Standards Post Market Regulation & Studies BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window